Altimmune, Inc

(NASDAQ:ALT)

Latest On Altimmune, Inc (ALT):

Date/Time Type Description Signal Details
2023-05-11 16:23 ESTNewsAltimmune GAAP EPS of -$0.40 beats by $0.08N/A
2023-05-11 16:22 ESTNewsAltimmune, Inc. (ALT) Q1 2023 Earnings Call TranscriptN/A
2023-05-10 12:33 ESTNewsAltimmune: A Story, It Seems, Of Too Little Too LateN/A
2023-03-22 23:18 ESTNewsAltimmune hits 10-month low as Goldman Sachs downgrades on weight loss dataN/A
2023-03-21 16:21 ESTNewsAltimmune stock slumps ~35% amid phase 2 trial data of obesity drug pemvidutideN/A
2023-03-21 16:20 ESTNewsAltimmune leads obesity drug developers lower after data for lead assetN/A
2023-02-28 16:09 ESTNewsAltimmune GAAP EPS of -$0.43 beats by $0.11N/A
2023-02-28 16:07 ESTNewsAltimmune (ALT) Q4 2022 Earnings Call TranscriptN/A
2023-02-28 01:16 ESTNewsAltimmune Q4 2022 Earnings PreviewN/A
2023-02-23 11:31 ESTNewsAltimmune's Peptide-Based Therapies Offer Substantial OpportunityN/A
2023-02-21 21:15 ESTNewsAltimmune: Potential Dual Action For Pemvidutide In Obesity, NASHN/A
2022-12-21 01:07 ESTNewsAltimmune rises 5% on positive data from phase 1 trial of Non-Alcoholic Fatty Liver Disease treatmentN/A
2022-12-02 18:36 ESTNewsAltimmune Appears To Have A Winner, But Will The Market Believe?N/A
2022-12-02 01:08 ESTNewsAltimmune spikes as Goldman Sachs sees over 100% upsideN/A
2022-11-30 13:10 ESTNewsAltimmune: Weight Loss Data Signals A Costly ConfusionN/A
2022-11-11 05:50 ESTNewsAltimmune, Inc. (ALT) Q3 2022 Earnings Call TranscriptN/A
2022-11-10 12:39 ESTNewsAltimmune GAAP EPS of -$0.48 beats by $0.01N/A
2022-11-10 12:38 ESTNewsAltimmune rises 5.2% on smaller-than-expected Q3 lossN/A
2022-09-16 22:56 ESTNewsAltimmune defended at H.C. Wainwright ahead of key readout for obesity drugN/A
2022-09-15 11:25 ESTNewsAltimmune: Overreaction On NASH Data Creates Buying OpportunityN/A
2022-09-14 18:07 ESTNewsAltimmune stock slumps 56% despite drug meeting main goal of reducing liver fat in trialN/A
2022-09-14 18:07 ESTNewsPiper Sandler sees Altimmune liver/obesity drug competitive despite weight loss dataN/A
2022-09-07 13:52 ESTNewsReassessing AltimmuneN/A
2022-09-01 01:36 ESTNewsAltimmune sets new 52-week high on rising volumeN/A
2022-08-11 22:36 ESTNewsAltimmune GAAP EPS of -$0.42 beats by $0.05, revenue of $8KN/A
2022-08-11 22:36 ESTNewsAltimmune quarterly net loss narrows as it beats on the bottom lineN/A
2022-08-11 22:36 ESTNewsAltimmune, Inc. (ALT) CEO Vipin Garg on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-11 05:48 ESTNewsAltimmune Q2 2022 Earnings PreviewN/A
2022-06-29 11:28 ESTNewsAltimmune: Several Catalysts In 2 Large Market Indications This YearN/A
2022-05-13 06:49 ESTNewsAltimmune, Inc. (ALT) CEO Vipin K. Garg on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-12 12:17 ESTNewsAltimmune GAAP EPS of -$0.44 beats by $0.14, revenue of $0.03M misses by $0.85MN/A
2022-05-11 18:31 ESTNewsAltimmune Q1 2022 Earnings PreviewN/A
2022-04-07 19:53 ESTNewsAltimmune's New Avatar As A Liver Disease PlayerN/A
2022-04-01 18:50 ESTNewsAltimmune begins enrollment in phase 2 trial of pemvidutide to treat obesityN/A
2022-03-15 16:28 ESTNewsAltimmune GAAP EPS of -$0.57 beats by $0.08, revenue of $3.28M beats by $3.19MN/A
2022-03-15 16:28 ESTNewsAltimmune stock falls ~5% despite Q4 beatN/A
2022-03-15 16:28 ESTNewsAltimmune, Inc. (ALT) CEO Vipin Garg on Q4 2021 Results - Earnings Call TranscriptN/A
2022-01-31 13:06 ESTNewsFDA clears Altimmune's pemvidutide application for obesityN/A
2022-01-03 16:07 ESTNewsAltimmune: Changing Focus To Pemvidutide In 2022N/A
2021-12-13 14:56 ESTNewsNew finance chief at AltimmuneN/A
2021-11-23 16:46 ESTNewsWarning: ALT is at high risk of performing badlyN/A
2021-11-22 18:32 ESTNewsAltimmune (ALT) Presents At 2021 Virtual Healthcare Conference - SlideshowN/A
2021-11-11 20:59 ESTNewsAltimmune, Inc.'s (ALT) CEO Vipin Garg on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-11 00:44 ESTNewsAltimmune EPS misses by $0.38, beats on revenueN/A
2021-11-11 00:43 ESTNewsAltimmune, Inc. (ALT) CEO Vipin Garg on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-10 02:01 ESTNewsAltimmune Q3 2021 Earnings PreviewN/A
2021-10-16 20:22 ESTNewsAltimmune: Changing The ThesisN/A
2021-10-04 22:54 ESTNewsAltimmune initiates Phase 1b trial of pemvidutide in non-alcoholic fatty liver diseaseN/A
2021-09-28 11:25 ESTNewsAltimmune spikes on data readout for obesity therapy tomorrowN/A
2021-09-28 11:25 ESTNewsAltimmune slips after posting 12-week data from Phase 1 trial for weight loss therapyN/A

About Altimmune, Inc (ALT):

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing intranasal vaccines, immune modulating therapies, and treatments for liver disease. The company develops AdCOVID, a single-dose intranasal vaccine that is in Phase I clinical trial to protect against COVID-19; T-COVID, an intranasal immune modulating therapeutic candidate, which is in Phase I/II clinical trial to evaluate the potential of T-COVID to prevent clinical worsening in patients with early COVID-19; NasoShield, an anthrax vaccine product candidate that is in a Phase 1b trial; and NasoVAX, a recombinant intranasal vaccine product candidate, which completed Phase IIa clinical trial for the treatment of seasonal and pandemic use. It also focuses on developing ALT-801, a novel peptide-based dual GLP-1/glucagon receptor agonist for the treatment of non-alcoholic steatohepatitis that is in Phase I clinical trial; and HepTcell, an immunotherapeutic product candidate, which is in Phase II clinical trial for patients chronically infected with the hepatitis B virus. Altimmune, Inc. has a collaboration with the University of Alabama at Birmingham for the development of AdCOVID. The company is headquartered in Gaithersburg, Maryland.

ALT Quotes by TradingView

See Advanced Chart

General

  • Name Altimmune, Inc
  • Symbol ALT
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 43
  • Last Split Factor1:30
  • Last Split Date2018-09-14
  • Fiscal Year EndDecember
  • IPO Date2005-10-06
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://altimmune.com
View More

Valuation

  • Trailing PE 1.82
  • Price/Sales (Trailing 12 Mt.) 54.44
  • Price/Book (Most Recent Quarter) 2.86
  • Enterprise Value Revenue 52.73
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.04
  • Next Year EPS Estimate $0.70
  • Next Quarter EPS Estimate -$0.18
  • Operating Margin -471%
  • Return on Assets -16%
  • Return on Equity -36%
  • Revenue 8.19 million
  • Earnings Per Share -$4.16
  • Revenue Per Share $0.32
  • Gross Profit -25324291
  • Quarterly Earnings Growth 301.7%
View More

Highlights

  • Market Capitalization 641.59 million
  • EBITDA -11790191
  • Analyst Target Price $41.83
  • Book Value Per Share $6.11
View More

Share Statistics

  • Shares Outstanding 37.15 million
  • Shares Float 29.2 million
  • % Held by Insiders 651%
  • % Held by Institutions 67.3%
  • Shares Short 2.41 million
  • Shares Short Prior Month 2.52 million
  • Short Ratio 1.22
  • Short % of Float 8%
  • Short % of Shares Outstanding 7%
View More

Technicals

  • Beta 1.37
  • 52 Week High $35.1
  • 52 Week Low $2.68
  • 50 Day Moving Average 17.82
  • 200 Day Moving Average 13.78
View More

Dividends

  • Dividend Date 2018-09-14
  • ExDividend Date 2017-01-20
  • Dividend Yield 0%
View More

Altimmune, Inc (ALT) Dividend Calendar:

ALT's last dividend payment was made to shareholders on September 14, 2018.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Altimmune, Inc (ALT) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$2.31 million-$0.17-$0.8078.84%
2020-09-302020-11-09$2.94 million-$0.54-$0.7628.95%
2020-06-302020-08-11$N/A-$0.94-$0.29-229.82%
2020-03-312020-05-13$2.21 million-$0.26-$0.3218.75%
2019-12-312020-03-27$N/A-$0.25-$0.263.85%
2019-09-302019-11-13$643978-$0.74-$0.19-289.47%
2019-06-302019-08-13$1.63 million-$0.26-$0.25-4%
2019-03-312019-04-01$2.96 million-$0.27-$2.8090.36%
2018-12-312019-03-31$2.59 million-$2.34-$2.8016.43%
2018-09-302018-11-13$2.63 million-$1.73-$3.6051.94%
2018-06-302018-08-14$2.42 million-$10.20-$4.50-126.67%
2018-03-312018-05-15$2.69 million-$8.73-$15.0041.78%
2017-12-312018-03-28$2.3 million-$2.40-$15.0084%
2017-09-302017-11-09$4.59 million-$10.20-$8.40-21.43%
2017-06-302017-08-10$3.04 million-$7.73
2014-09-302014-11-06$962451-$24.00-$7.50-220%
2014-06-302014-08-04$3.66 million-$3.00-$16.5081.82%
2014-03-312014-05-08$3.74 million-$12.00-$18.0033.33%
2013-12-312014-03-11$3.65 million-$24.00-$15.00-60%
2013-09-302013-11-07$3.49 million-$24.00-$10.50-128.57%
2013-06-302013-08-07$4.3 million-$6.00-$9.0033.33%
2013-03-312013-05-08$6.48 million-$12.00-$15.0020%
2012-12-312013-03-13$6.01 million-$6.00-$12.0050%
2012-09-302012-11-06$6.7 million-$1.33-$9.0085.25%
2012-06-302012-08-07$6.32 million-$6.00-$9.0033.33%
2012-03-312012-05-08$6.15 million-$18.00-$15.00-20%
2011-12-312012-03-08$3.00-$32.00109.38%
2011-09-302011-11-09$5.26 million-$0.21-$25.0099.17%
2011-06-302011-08-10$6.43 million-$15.00-$31.5052.38%
2011-03-312011-05-11-$12.00-$29.0058.62%
2010-12-312011-03-28-$138.00-$26.00-430.77%
2010-09-302010-11-11-$42.00-$52.0019.23%
2010-06-302010-08-12-$66.00-$61.50-7.32%
2010-03-312010-05-11-$84.00-$51.00-64.71%
2009-12-312010-03-23-$60.00-$61.502.44%
2009-09-302009-11-12-$150.00-$57.00-163.16%
2009-06-302009-08-13-$72.00-$54.00-33.33%
2009-03-312009-05-15-$69.00-$60.00-15%
2008-12-312009-03-30-$51.00-$78.0034.62%
2008-09-302008-11-13-$60.00-$78.0023.08%
2008-06-302008-08-13-$296.82
2008-03-312008-05-14-$68.15
2007-09-302007-11-13-$20.56
2007-03-312007-03-31$7.48
2006-12-312006-12-31-$11,895.61
2006-09-302006-09-30$6.64
2006-06-302006-06-30$6.11
2006-03-312006-03-31$4.47
2005-12-312005-12-31$4.81

Altimmune, Inc (ALT) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Altimmune, Inc (ALT) Chart:

Altimmune, Inc (ALT) News:

Below you will find a list of latest news for Altimmune, Inc (ALT) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Altimmune, Inc (ALT) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-08-070.50CALL0 3119916.82TRUE00
2026-08-0712.1CALL0 132795.68TRUE00
2026-08-071.51.43CALL3 431570.45TRUE1.430
2026-08-0720CALL0 63233.73TRUE00
2026-08-072.50CALL0 11371.46TRUE00
2026-08-0730.1CALL268 2023148.12FALSE-0.05-0.33
2026-08-073.50.04CALL3 471139.22FALSE0.040
2026-08-0740CALL0 321259.3FALSE00
2026-08-074.50CALL0 14471.7FALSE00
2026-08-0750CALL0 0318.85FALSE00
2026-08-075.50CALL0 0808.78FALSE00
2026-08-0760CALL0 0601.76FALSE00
2026-08-070.50PUT0 0824.79FALSE00
2026-08-0710PUT0 451137.7FALSE00
2026-08-071.50PUT0 241192.34FALSE00
2026-08-0720PUT0 19537.05FALSE00
2026-08-072.50PUT0 4282.44FALSE00
2026-08-0730.25PUT101 1055126.08TRUE0.050.25
2026-08-073.50.7PUT202 3105.65TRUE0.180.35
2026-08-0740PUT0 2152.17TRUE00
2026-08-074.50PUT0 1357.49TRUE00
2026-08-0752.15PUT0 1474.72TRUE00
2026-08-075.50PUT0 0842.36TRUE00
2026-08-0760PUT0 2864.69TRUE00
2026-08-140.52.62CALL0 179718.11TRUE00
2026-08-1411.98CALL23 613680.12TRUE1.980
2026-08-141.51.35CALL0 31372.32TRUE00
2026-08-1420CALL0 146219.33TRUE00
2026-08-142.50CALL0 0438.53TRUE00
2026-08-1430.18CALL2 284151.27FALSE-0.02-0.1
2026-08-143.50.05CALL16 126125.27FALSE00
2026-08-1440.05CALL0 19444.31FALSE00
2026-08-144.50CALL0 0596.86FALSE00
2026-08-1450CALL0 0366.44FALSE00
2026-08-145.50CALL0 0614.37FALSE00
2026-08-1460CALL0 5529.32FALSE00
2026-08-140.50.19PUT0 19553.93FALSE00
2026-08-1410.19PUT0 340FALSE00
2026-08-141.50.19PUT6 0662.54FALSE0.190
2026-08-1420PUT0 1386.48FALSE00
2026-08-142.50PUT0 0415.01FALSE00
2026-08-1430.25PUT0 504123.08TRUE00
2026-08-143.50.7PUT100 1000TRUE0.050.08
2026-08-1440PUT0 1315.33TRUE00
2026-08-144.50PUT0 0249.62TRUE00
2026-08-1450PUT0 2155.04TRUE00
2026-08-145.50PUT0 0234.74TRUE00
2026-08-1460PUT0 0195.98TRUE00
2026-08-210.52.95CALL0 3820TRUE00
2026-08-2111.72CALL0 180448.35TRUE00
2026-08-211.50CALL0 74327.46TRUE00
2026-08-2121.25CALL0 10377.47TRUE00
2026-08-212.50CALL0 7270.04TRUE00
2026-08-2130.17CALL21 2384121.6FALSE-0.06-0.26
2026-08-213.50.08CALL39 13568123.51FALSE-0.02-0.2
2026-08-2140CALL0 997157.45FALSE00
2026-08-214.50CALL0 140332.87FALSE00
2026-08-2150CALL0 243162.53FALSE00
2026-08-215.50CALL0 6328.17FALSE00
2026-08-210.50PUT0 0441.41FALSE00
2026-08-2110.06PUT40 21609.55FALSE0.060
2026-08-211.50.05PUT10 9267.64FALSE0.050
2026-08-2120PUT0 1130.98FALSE00
2026-08-212.50.05PUT0 54238.85FALSE00
2026-08-2130.3PUT10 154634.3TRUE00
2026-08-213.50PUT0 110TRUE00
2026-08-2140PUT0 1190.74TRUE00
2026-08-214.50PUT0 2113.32TRUE00
2026-08-2150PUT0 0133.48TRUE00
2026-08-215.50PUT0 2151.72TRUE00
2026-08-2811.72CALL3 173370.31TRUE-0.17-0.09
2026-08-2820CALL0 0161.97TRUE00
2026-08-2830.25CALL1 22158.38FALSE0.250
2026-08-2840CALL0 470155.21FALSE00
2026-08-2850.05CALL5 1374.56FALSE00
2026-08-2860.02CALL0 15234.01FALSE00
2026-08-2810.08PUT16 25822.99FALSE0.080
2026-08-2820PUT0 14262.82FALSE00
2026-08-2830.42PUT3 320TRUE00
2026-08-2840PUT0 0217.52TRUE00
2026-08-2850PUT0 0375.27TRUE00
2026-08-2860PUT0 0347.36TRUE00
2026-09-0412.36CALL20 91450.36TRUE2.360
2026-09-0420CALL0 0467.18TRUE00
2026-09-0430CALL0 0427.1FALSE00
2026-09-0440CALL0 3203.49FALSE00
2026-09-0450CALL0 0359FALSE00
2026-09-0460CALL0 0394.18FALSE00
2026-09-0410PUT0 24702.78FALSE00
2026-09-0420PUT0 0530.96FALSE00
2026-09-0430PUT0 00TRUE00
2026-09-0440PUT0 0124.32TRUE00
2026-09-0450PUT0 0111TRUE00
2026-09-0460PUT0 0248.52TRUE00
2026-09-1111.89CALL6 56498.42TRUE-0.06-0.03
2026-09-1120CALL0 0441.25TRUE00
2026-09-1130.35CALL2 0233.5FALSE0.350
2026-09-1140CALL0 0191.72FALSE00
2026-09-1150CALL0 0487.88FALSE00
2026-09-1160CALL0 0519.39FALSE00
2026-09-1110PUT0 0547.94FALSE00
2026-09-1120PUT0 083.67FALSE00
2026-09-1130PUT0 070.2TRUE00
2026-09-1140PUT0 0211.31TRUE00
2026-09-1150PUT0 0101.66TRUE00
2026-09-1160PUT0 079.35TRUE00
2026-09-180.52.2CALL1 155741.12TRUE-0.6-0.21
2026-09-1810CALL0 46330.14TRUE00
2026-09-181.50CALL0 0458.45TRUE00
2026-09-1820CALL0 511148.06TRUE00
2026-09-182.50.45CALL15 261147.36TRUE0.450
2026-09-1830.27CALL96 3487130.29FALSE-0.06-0.18
2026-09-183.50.15CALL38 4120125.73FALSE-0.04-0.21
2026-09-1840.11CALL93 3849130.72FALSE-0.02-0.15
2026-09-184.50CALL0 1067149.07FALSE00
2026-09-1850.07CALL40 6885152.51FALSE0.020.4
2026-09-185.50.05CALL0 453150.74FALSE00
2026-09-1860.05CALL8 2079161.58FALSE00
2026-09-1870CALL0 594311.07FALSE00
2026-09-1880CALL0 325195.59FALSE00
2026-09-1890.01CALL0 157185.5FALSE00
2026-09-18100CALL0 442196.32FALSE00
2026-09-180.50PUT0 3271.33FALSE00
2026-09-1810PUT0 18209.17FALSE00
2026-09-181.50PUT0 788.71FALSE00
2026-09-1820.05PUT0 19168.1FALSE00
2026-09-182.50PUT0 660FALSE00
2026-09-1830.4PUT10 107442.33TRUE0.050.14
2026-09-183.50.83PUT1 1064.16TRUE0.830
2026-09-1840PUT0 29263.19TRUE00
2026-09-184.50PUT0 1082.76TRUE00
2026-09-1850PUT0 9099.24TRUE00
2026-09-185.50PUT0 0113.89TRUE00
2026-09-1860PUT0 110TRUE00
2026-09-1870PUT0 10TRUE00
2026-09-1880PUT0 0121.57TRUE00
2026-09-1890PUT0 0154.77TRUE00
2026-09-18100PUT0 0136.95TRUE00
2026-12-180.50CALL0 1616.74TRUE00
2026-12-1811.95CALL0 4574.63TRUE00
2026-12-181.50CALL0 0433.83TRUE00
2026-12-1820CALL0 17213.24TRUE00
2026-12-182.50CALL0 40216.88TRUE00
2026-12-1830.59CALL0 515177.34FALSE00
2026-12-183.50.43CALL0 79178.36FALSE00
2026-12-1840.32CALL415 570152.35FALSE0.320
2026-12-184.50CALL0 23153.36FALSE00
2026-12-1850CALL0 904181.44FALSE00
2026-12-185.50CALL0 34244.31FALSE00
2026-12-1860CALL0 449226.25FALSE00
2026-12-180.50PUT0 1131.92FALSE00
2026-12-1810PUT0 0259.56FALSE00
2026-12-181.50PUT0 5146.55FALSE00
2026-12-1820PUT0 840FALSE00
2026-12-182.50PUT0 330FALSE00
2026-12-1830.72PUT1 3650TRUE0.720
2026-12-183.51PUT1 150TRUE10
2026-12-1840PUT0 540TRUE00
2026-12-184.50PUT0 00TRUE00
2026-12-1850PUT0 00TRUE00
2026-12-185.50PUT0 00TRUE00
2026-12-1860PUT0 60TRUE00
2027-01-150.50CALL0 41094.29TRUE00
2027-01-1510CALL0 182292.65TRUE00
2027-01-151.50CALL0 101271.41TRUE00
2027-01-1521.1CALL1 6758238.01TRUE1.10
2027-01-152.50CALL0 129185.84TRUE00
2027-01-1530.57CALL84 5233193.81FALSE0.570
2027-01-153.50.45CALL11 3330169.62FALSE-0.05-0.1
2027-01-1540.32CALL26 6573169.86FALSE-0.08-0.2
2027-01-154.50CALL0 95160.95FALSE00
2027-01-1550.25CALL0 10524165.14FALSE00
2027-01-155.50.24CALL0 326155.2FALSE00
2027-01-1560CALL0 164148.12FALSE00
2027-01-1570.15CALL21 5754159.52FALSE0.150
2027-01-15100.1CALL31 9813174.92FALSE00
2027-01-15120CALL0 1392175.91FALSE00
2027-01-15150CALL0 1885251.5FALSE00
2027-01-15170CALL0 2850239.27FALSE00
2027-01-15200.06CALL1 17638215.32FALSE0.060
2027-01-150.50PUT0 2112.08FALSE00
2027-01-1510PUT0 68183.7FALSE00
2027-01-151.50PUT0 147.53FALSE00
2027-01-1520PUT0 3760FALSE00
2027-01-152.50.4PUT20 3160FALSE0.40
2027-01-1530.72PUT6 7390TRUE0.720
2027-01-153.50PUT0 00TRUE00
2027-01-1540PUT0 13340TRUE00
2027-01-154.50PUT0 080.07TRUE00
2027-01-1552.2PUT0 13340TRUE00
2027-01-155.50PUT0 00TRUE00
2027-01-1560PUT0 00TRUE00
2027-01-1570PUT0 5600TRUE00
2027-01-15100PUT0 324107.66TRUE00
2027-01-15120PUT0 21129.83TRUE00
2027-01-15150PUT0 1142.72TRUE00
2027-01-15170PUT0 0134.16TRUE00
2027-01-15200PUT0 0141.5TRUE00
2027-03-190.50CALL0 0609.52TRUE00
2027-03-1910CALL0 0292.43TRUE00
2027-03-191.50CALL0 0382.71TRUE00
2027-03-1920CALL0 0238.11TRUE00
2027-03-192.50CALL0 0242.05TRUE00
2027-03-1930CALL0 97342.27FALSE00
2027-03-193.50CALL0 0262.38FALSE00
2027-03-1940.48CALL76 2305183.91FALSE0.480
2027-03-194.50CALL0 0237.45FALSE00
2027-03-1950CALL0 20223.19FALSE00
2027-03-195.50CALL0 0236.14FALSE00
2027-03-1960CALL0 0238.31FALSE00
2027-03-190.50PUT0 50078.68FALSE00
2027-03-1910PUT0 0409.15FALSE00
2027-03-191.50PUT0 042.68FALSE00
2027-03-1920PUT0 120FALSE00
2027-03-192.50PUT0 00FALSE00
2027-03-1930PUT0 00TRUE00
2027-03-193.50PUT0 068.32TRUE00
2027-03-1940PUT0 00TRUE00
2027-03-194.50PUT0 00TRUE00
2027-03-1950PUT0 074.69TRUE00
2027-03-195.50PUT0 00TRUE00
2027-03-1960PUT0 00TRUE00
2028-01-210.52.44CALL102 1741021.86TRUE2.440
2028-01-2112.09CALL120 137454.34TRUE2.090
2028-01-211.50CALL0 331096.6TRUE00
2028-01-2121.62CALL6 162356.03TRUE1.620
2028-01-212.51.39CALL6 17318.99TRUE1.390
2028-01-2131.21CALL107 16558319.81FALSE-0.04-0.03
2028-01-213.51.06CALL49 81268.71FALSE-0.09-0.08
2028-01-2141.14CALL23 931279.05FALSE0.140.14
2028-01-214.50CALL0 6550FALSE00
2028-01-2150CALL0 953335.05FALSE00
2028-01-215.50CALL0 1210FALSE00
2028-01-2170CALL0 2450246.33FALSE00
2028-01-21100.5CALL5 8158272.11FALSE0.030.06
2028-01-210.50PUT0 340FALSE00
2028-01-2110PUT0 130FALSE00
2028-01-211.50PUT0 20FALSE00
2028-01-2120PUT0 110FALSE00
2028-01-212.50PUT0 00FALSE00
2028-01-2130PUT0 2676.57TRUE00
2028-01-213.50PUT0 069.44TRUE00
2028-01-2140PUT0 1798.54TRUE00
2028-01-214.50PUT0 4395TRUE00
2028-01-2150PUT0 4389.86TRUE00
2028-01-215.50PUT0 083.76TRUE00
2028-01-2170PUT0 4263.25TRUE00
2028-01-21100PUT0 10353.38TRUE00

Latest ALT Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST1$9.25
Jun 13, 2022 7:59 PM EST399$9.25
Jun 13, 2022 7:59 PM EST58$9.25
Jun 13, 2022 7:59 PM EST100$9.25
Jun 13, 2022 7:59 PM EST200$9.235

Altimmune, Inc (ALT) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320018161/0000899243-20-018161-index.htm
2019-04-15UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1326190/000000000019007165/0000000000-19-007165-index.htm
2019-08-16UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1326190/000000000019012559/0000000000-19-012559-index.htm
2019-08-22UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1326190/000000000019012749/0000000000-19-012749-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924319016650/0000899243-19-016650-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924319017407/0000899243-19-017407-index.htm
2019-09-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924319022846/0000899243-19-022846-index.htm
2019-09-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924319023316/0000899243-19-023316-index.htm
2019-09-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924319023318/0000899243-19-023318-index.htm
2019-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924319028409/0000899243-19-028409-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320000074/0000899243-20-000074-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320000275/0000899243-20-000275-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320000276/0000899243-20-000276-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320000279/0000899243-20-000279-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320000286/0000899243-20-000286-index.htm
2020-02-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320002630/0000899243-20-002630-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320002960/0000899243-20-002960-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320002986/0000899243-20-002986-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320003006/0000899243-20-003006-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320006772/0000899243-20-006772-index.htm
2020-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320009897/0000899243-20-009897-index.htm
2020-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320011911/0000899243-20-011911-index.htm
2020-05-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320012836/0000899243-20-012836-index.htm
2020-05-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320012840/0000899243-20-012840-index.htm
2020-05-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320013395/0000899243-20-013395-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320014937/0000899243-20-014937-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320017823/0000899243-20-017823-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320017824/0000899243-20-017824-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320017826/0000899243-20-017826-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320017831/0000899243-20-017831-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320017833/0000899243-20-017833-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320017835/0000899243-20-017835-index.htm
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320018161/0000899243-20-018161-index.htm
2020-08-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320021020/0000899243-20-021020-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320021205/0000899243-20-021205-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320021207/0000899243-20-021207-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320021212/0000899243-20-021212-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320021219/0000899243-20-021219-index.htm
2020-08-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320023683/0000899243-20-023683-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026409/0000899243-20-026409-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026410/0000899243-20-026410-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026411/0000899243-20-026411-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026412/0000899243-20-026412-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026413/0000899243-20-026413-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026414/0000899243-20-026414-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026415/0000899243-20-026415-index.htm
2020-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026921/0000899243-20-026921-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320028535/0000899243-20-028535-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320028536/0000899243-20-028536-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320028537/0000899243-20-028537-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320028538/0000899243-20-028538-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320028539/0000899243-20-028539-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320028540/0000899243-20-028540-index.htm
2020-11-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320030113/0000899243-20-030113-index.htm
2019-03-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000092542119000135/0000925421-19-000135-index.htm
2019-03-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000092542119000137/0000925421-19-000137-index.htm
2018-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297518001065/0001012975-18-001065-index.htm
2018-10-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297518001091/0001012975-18-001091-index.htm
2018-10-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297518001100/0001012975-18-001100-index.htm
2018-12-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297518001271/0001012975-18-001271-index.htm
2018-12-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297518001273/0001012975-18-001273-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000028/0001012975-19-000028-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000029/0001012975-19-000029-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000031/0001012975-19-000031-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000033/0001012975-19-000033-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000035/0001012975-19-000035-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000037/0001012975-19-000037-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000039/0001012975-19-000039-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000041/0001012975-19-000041-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000043/0001012975-19-000043-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000106823820000055/0001068238-20-000055-index.htm
2018-10-05SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000110465918060692/0001104659-18-060692-index.htm
2019-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000110465919005825/0001104659-19-005825-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000110465919008563/0001104659-19-008563-index.htm
2020-06-01SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000110465920068336/0001104659-20-068336-index.htm
2020-06-25SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1326190/000110465920076855/0001104659-20-076855-index.htm
2020-09-24SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000110465920108310/0001104659-20-108310-index.htm
2020-10-05SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000110465920112175/0001104659-20-112175-index.htm
2018-09-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518280602/0001193125-18-280602-index.htm
2018-09-24424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1326190/000119312518280966/0001193125-18-280966-index.htm
2018-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518281668/0001193125-18-281668-index.htm
2018-09-26S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1326190/000119312518284095/0001193125-18-284095-index.htm
2018-09-27CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1326190/000119312518285764/0001193125-18-285764-index.htm
2018-09-27CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1326190/000119312518285783/0001193125-18-285783-index.htm
2018-09-28POS EXPost-effective amendment adding exhibits to registration statement [Rule 462(d)]https://www.sec.gov/Archives/edgar/data/1326190/000119312518286447/0001193125-18-286447-index.htm
2018-10-01424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1326190/000119312518289729/0001193125-18-289729-index.htm
2018-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518289763/0001193125-18-289763-index.htm
2018-10-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000119312518293265/0001193125-18-293265-index.htm
2018-10-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518295412/0001193125-18-295412-index.htm
2018-10-09424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1326190/000119312518295424/0001193125-18-295424-index.htm
2018-10-09424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1326190/000119312518296082/0001193125-18-296082-index.htm
2018-10-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518304261/0001193125-18-304261-index.htm
2018-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518325584/0001193125-18-325584-index.htm
2018-11-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1326190/000119312518325587/0001193125-18-325587-index.htm
2018-11-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518335258/0001193125-18-335258-index.htm
2018-11-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518339667/0001193125-18-339667-index.htm
2018-11-30S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1326190/000119312518339756/0001193125-18-339756-index.htm
2018-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518340078/0001193125-18-340078-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000119312519033928/0001193125-19-033928-index.htm
2019-03-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519067835/0001193125-19-067835-index.htm
2019-03-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519070141/0001193125-19-070141-index.htm
2019-03-11424B2Prospectus [Rule 424(b)(2)]https://www.sec.gov/Archives/edgar/data/1326190/000119312519070146/0001193125-19-070146-index.htm
2019-03-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519076851/0001193125-19-076851-index.htm
2019-04-04S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1326190/000119312519097986/0001193125-19-097986-index.htm
2019-04-04S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1326190/000119312519097996/0001193125-19-097996-index.htm
2019-04-11CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1326190/000119312519103831/0001193125-19-103831-index.htm
2019-04-11CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1326190/000119312519104131/0001193125-19-104131-index.htm
2019-06-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519168149/0001193125-19-168149-index.htm
2019-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519171212/0001193125-19-171212-index.htm
2019-06-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519178904/0001193125-19-178904-index.htm
2019-07-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519190926/0001193125-19-190926-index.htm
2019-07-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519193586/0001193125-19-193586-index.htm
2019-08-09PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1326190/000119312519218069/0001193125-19-218069-index.htm
2019-08-14S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1326190/000119312519221188/0001193125-19-221188-index.htm
2019-08-19CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1326190/000119312519224352/0001193125-19-224352-index.htm
2019-08-19PRER14APreliminary Proxy Soliciting materialshttps://www.sec.gov/Archives/edgar/data/1326190/000119312519224357/0001193125-19-224357-index.htm
2019-08-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519225595/0001193125-19-225595-index.htm
2019-08-22DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1326190/000119312519226618/0001193125-19-226618-index.htm
2019-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519259847/0001193125-19-259847-index.htm
2020-03-27424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1326190/000119312520087649/0001193125-20-087649-index.htm
2020-03-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520088680/0001193125-20-088680-index.htm
2020-04-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520100902/0001193125-20-100902-index.htm
2020-05-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520139801/0001193125-20-139801-index.htm
2020-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520156447/0001193125-20-156447-index.htm
2020-06-01424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1326190/000119312520156472/0001193125-20-156472-index.htm
2020-07-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520191485/0001193125-20-191485-index.htm
2020-07-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1326190/000119312520191866/0001193125-20-191866-index.htm
2020-07-15424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1326190/000119312520192791/0001193125-20-192791-index.htm
2020-07-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520194024/0001193125-20-194024-index.htm
2020-07-168-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520194052/0001193125-20-194052-index.htm
2020-08-21DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1326190/000119312520226963/0001193125-20-226963-index.htm
2020-08-21S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1326190/000119312520226971/0001193125-20-226971-index.htm
2020-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520254566/0001193125-20-254566-index.htm
2020-02-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000120919120009672/0001209191-20-009672-index.htm
2018-10-17SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000121390018014006/0001213900-18-014006-index.htm
2019-02-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000121390019001904/0001213900-19-001904-index.htm
2020-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000121390020003212/0001213900-20-003212-index.htm
2019-02-01SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000139382519000035/0001393825-19-000035-index.htm
2020-01-31SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000139382520000012/0001393825-20-000012-index.htm
2019-04-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1326190/000156459019010429/0001564590-19-010429-index.htm
2019-04-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000156459019010435/0001564590-19-010435-index.htm
2019-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1326190/000156459019019139/0001564590-19-019139-index.htm
2019-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000156459019019146/0001564590-19-019146-index.htm
2019-08-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1326190/000156459019031795/0001564590-19-031795-index.htm
2019-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000156459019031811/0001564590-19-031811-index.htm
2019-11-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1326190/000156459019043231/0001564590-19-043231-index.htm
2019-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000156459019043240/0001564590-19-043240-index.htm
2020-03-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000156459020013376/0001564590-20-013376-index.htm
2020-03-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1326190/000156459020013377/0001564590-20-013377-index.htm
2020-05-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1326190/000156459020025123/0001564590-20-025123-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000156459020025137/0001564590-20-025137-index.htm
2020-08-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000156459020039298/0001564590-20-039298-index.htm
2020-08-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1326190/000156459020039314/0001564590-20-039314-index.htm
2020-05-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000173804820000001/0001738048-20-000001-index.htm
2020-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000173804820000003/0001738048-20-000003-index.htm
2018-09-27EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1326190/999999999518002478/9999999995-18-002478-index.htm
2019-04-12EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1326190/999999999519000701/9999999995-19-000701-index.htm
2018-10-04CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1326190/999999999718008376/9999999997-18-008376-index.htm

Altimmune, Inc (ALT) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Altimmune, Inc (ALT). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 651%
Institutional Ownership: 6730%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-07-31William Michael BrownChief Financial OfficerBuy7,920.001.4611,563.2015,981.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320021212/0000899243-20-021212-index.htm
2020-05-15VELOCITY PHARMACEUTICAL HOLDINGS LLC10% Share HolderSell30,622.004.65142,392.301,687,250.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320013395/0000899243-20-013395-index.htm
2020-05-14VELOCITY PHARMACEUTICAL HOLDINGS LLC10% Share HolderSell169,378.004.81814,708.181,717,872.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320013395/0000899243-20-013395-index.htm
2018-10-09Wayne PisanoDirectorBuy2,000.004.599,180.002,000.00https://www.sec.gov/Archives/edgar/data/1326190/000101297518001100/0001012975-18-001100-index.htm
2020-05-26Venrock Healthcare Capital Partners III, L.P.10% Share HolderBuy309,453.008.792,720,091.872,005,817.00https://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm
2020-05-26Venrock Healthcare Capital Partners III, L.P.10% Share HolderBuy390,547.009.783,819,549.662,396,364.00https://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm
2020-05-27Venrock Healthcare Capital Partners III, L.P.10% Share HolderBuy125,162.007.23904,921.262,521,526.00https://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm
2020-05-27Venrock Healthcare Capital Partners III, L.P.10% Share HolderBuy277,000.007.922,193,840.002,798,526.00https://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm
2020-05-28Venrock Healthcare Capital Partners III, L.P.10% Share HolderBuy27,763.007.79216,273.772,826,289.00https://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm
2020-05-28Venrock Healthcare Capital Partners III, L.P.10% Share HolderBuy173,711.008.871,540,816.573,000,000.00https://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm
2018-11-30Vipin K GargPresident and CEOBuy322,907.00322,907.00https://www.sec.gov/Archives/edgar/data/1326190/000101297518001273/0001012975-18-001273-index.htm
2020-07-31Vipin K GargChief Financial OfficerBuy11,674.001.4617,044.04325,789.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320021205/0000899243-20-021205-index.htm
2020-01-31Vipin K GargPresident and CEOBuy11,289.001.4616,481.94326,206.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320002986/0000899243-20-002986-index.htm
2019-09-05Vipin K GargPresident and CEOBuy20,000.002.1042,000.00342,907.00https://www.sec.gov/Archives/edgar/data/1326190/000089924319022846/0000899243-19-022846-index.htm
2020-06-15Venrock Healthcare Capital Partners III, L.P.10% Share HolderBuy1,500,000.007.5411,310,000.004,500,000.00https://www.sec.gov/Archives/edgar/data/1326190/000173804820000003/0001738048-20-000003-index.htm
2020-01-31M Scot RobertsChief Scientific OfficerBuy3,698.001.465,399.085,535.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320002960/0000899243-20-002960-index.htm
2020-01-31William Michael BrownChief Financial OfficerBuy8,061.001.4611,769.068,061.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320003006/0000899243-20-003006-index.htm
2020-07-31Matthew Scott HarrisChief Medical OfficerBuy8,084.001.4611,802.648,084.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320021219/0000899243-20-021219-index.htm
2020-07-31M Scot RobertsChief Scientific OfficerBuy3,859.001.465,634.149,394.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320021207/0000899243-20-021207-index.htm